MARKET

ESPR

ESPR

Esperion Therape
NASDAQ
2.890
-0.020
-0.69%
Opening 09:39 06/14 EDT
OPEN
2.880
PREV CLOSE
2.910
HIGH
2.940
LOW
2.830
VOLUME
1.08M
TURNOVER
0
52 WEEK HIGH
3.400
52 WEEK LOW
0.7000
MARKET CAP
547.54M
P/E (TTM)
-2.8762
1D
5D
1M
3M
1Y
5Y
Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Skye Bioscience shares tumbled 18.9% to $8.87 on Monday. Big Tree Cloud Holdings Limited shares jumped 123% in today's mid-day session. The company announced the completion of its business combination with Plutonian Acquisition Corp. Southwest Airlines shares rose 7.6% in Monday's session.
Benzinga · 3d ago
Weekly Report: what happened at ESPR last week (0603-0607)?
Weekly Report · 4d ago
Argan Reports Strong Earnings, Joins Geron, Planet Labs PBC And Other Big Stocks Moving Higher On Friday
Shares of Argan, Inc. Rose sharply after the company reported better-than-expected first-quarter financial results. The Dow Jones index gained around 0.1% on Friday. Geron Corporation shares climbed 26% as company reported FDA approval of a new drug. SunPower Corporation shares jumped 18.8% to $4.11.
Benzinga · 06/07 14:19
Weekly Report: what happened at ESPR last week (0527-0531)?
Weekly Report · 06/03 11:56
Esperion Stockholders Approve Key Proposals at Annual Meeting
TipRanks · 05/28 22:08
Weekly Report: what happened at ESPR last week (0520-0524)?
Weekly Report · 05/27 12:02
Esperion's (ESPR) Drugs Get EU Nod for Lowering Heart Risk
NASDAQ · 05/23 16:11
Esperion Therapeutics Price Target Maintained With a $16.00/Share by HC Wainwright & Co.
Dow Jones · 05/22 16:10
More
About ESPR
Esperion Therapeutics, Inc. is a pharmaceutical company. The Company is focused on developing and commercializing oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol (LDL-C). The Company's products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company's NEXLETOL and NEXLIZET (bempedoic acid and ezetimibe) tablets are oral, once-daily, non-statin medicines for the treatment of primary hyperlipidemia in adults with heterozygous familial hypercholesterolemia (HeFH) or atherosclerotic cardiovascular disease (ASCVD). Its NEXLETOL is an ATP Citrate Lyase (ACL), inhibitor that lowers LDL-C by reducing cholesterol biosynthesis and up-regulating the LDL receptors. Its NUSTENDI contains bempedoic acid and ezetimibe and lowers elevated LDL-C through complementary mechanisms of action by inhibiting cholesterol synthesis in the liver and absorption in the intestine. Its Pipeline product include Next Generation ACLYi.

Webull offers Esperion Therapeutics Inc stock information, including NASDAQ: ESPR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ESPR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ESPR stock methods without spending real money on the virtual paper trading platform.